The Chemotherapy Industry

According to today's "New York Times:" The academic journal "Health Affairs" reported that, after Congress cut back payments for certain cancer drugs, lung-cancer specialists in the aggregate who administer chemotherapy in their offices responded by treating more patients with chemotherapy and by switching to more expensive, but not necessarily more efficacious, drugs, thus recouping lost income.